Results 181 to 190 of about 7,770 (204)
Some of the next articles are maybe not open access.
Challenges for biosimilars: focus on rheumatoid arthritis
Critical Reviews in Biotechnology, 2021Muhammad Safwan Akram +2 more
exaly
Biosimilars in Oncology: Latest Trends and Regulatory Status
Pharmaceutics, 2022Saurabh Gupta +2 more
exaly
The Disappointment of the Biosimilar
Journal of Law, Medicine & Ethics, 2018openaire +2 more sources
No two classes of biosimilars: Urgent advice to the US Congress and theFDA
Journal of Clinical Pharmacy and Therapeutics, 2022Sarfaraz K Niazi
exaly
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
International Journal of Environmental Research and Public Health, 2020Vesa Halimi +2 more
exaly
Biosimilars: Review of regulatory, manufacturing, analytical aspects and beyond
Microchemical Journal, 2021Sami El Deeb, Fawzy Elbarbry
exaly
Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer
Biomedicines, 2022John Triantafillidis
exaly
Biosimilars: What the Oncologist should Know
Future Oncology, 2019, Marc Thill, Vladimir Hanes
exaly